News
- 2013-02-05
Alzheimer antibody enters into phase IIb
Read more » - 2012-05-22
BioArctic Neuroscience and Eisai Extend Research Collaboration
Read more » - 2012-04-03
BioArctic Receives Grant from VINNOVA
Read more » - 2011-10-25
Orphan Drug Designation in USA
Read more » - 2011-04-08
BioArctic founds SpineMedical AB
Read more »
Technology
Antibodies targeting toxic proteins
R&D
First drug candidate in development for Alzheimer’s disease
Therapeutic Area
